Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Cancer Research|January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumorsS A Fuqua, S D Fitzgerald, D C Allred, et al.
Experientia|October 15, 1978
Influence of pinealectomy on serum estrogen and progesterone levels in blind-anosmic female ratsG M Vaughan, R J Reiter, T M Siler-Khodr, et al.
Disease Markers|September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniquesR Molina, S Oesterreich, J L Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group studyP M Ravdin, S Green, T M Dorr, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
Cancer Research|April 1, 1980
Clinical correlations of steroid receptors and male breast cancerR B Everson, M E Lippman, E B Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Surgery|May 1, 1980
Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary reportC A Hubay, O H Pearson, J S Marshall, et al.
Pageof 20